{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T01:15:51Z","timestamp":1782177351149,"version":"3.54.5"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"23-24","license":[{"start":{"date-parts":[[2024,2,6]],"date-time":"2024-02-06T00:00:00Z","timestamp":1707177600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,2,6]],"date-time":"2024-02-06T00:00:00Z","timestamp":1707177600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005788","name":"Medical University of Vienna","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005788","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Wien Klin Wochenschr"],"published-print":{"date-parts":[[2024,12]]},"abstract":"<jats:title>Summary<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The effects of cardiovascular risk factors (CVRF) on the development of most acute cardiac conditions are well established; however, little is known about the frequency and effects of CVRF in Takotsubo syndrome (TTS) patients.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Objective<\/jats:title>\n                <jats:p>The aim of our study was to compare the frequency of CVRF and pre-existing diseases (PD) of TTS patients to ST-elevation myocardial infarction (STEMI) patients and analyze their effects on short-term outcome.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We analyzed the frequency of CVRF (hypertension, hyperlipidemia, type II diabetes mellitus, smoking, chronic kidney disease, family history) as well as somatic and psychiatric PD at admission in TTS patients and compared them with STEMI patients. Their effect on short-term outcome was calculated using a\u00a0combined endpoint of cardiogenic shock, cardiopulmonary resuscitation, mechanical ventilation, and\/or in-hospital death.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>In total, 150 TTS and 155 STEMI patients were included in our study. We observed a\u00a0higher frequency of psychiatric (30% vs. 7%, <jats:italic>p<\/jats:italic>\u202f&lt;\u20090.001), neurological (5% vs. 0%, <jats:italic>p<\/jats:italic>\u202f=\u20090.01), and pulmonary (18% vs. 5%, <jats:italic>p<\/jats:italic>\u202f&lt;\u20090.001) PD in TTS patients as compared to STEMI patients. There were less smokers (47% vs. 61%, <jats:italic>p<\/jats:italic>\u202f=\u20090.03) and patients with hyperlipidemia (24% vs. 51%, <jats:italic>p<\/jats:italic>\u202f&lt;\u20090.001) in the TTS cohort than in the STEMI cohort. None of the CVRF or PD behaved as an independent predictor for adverse short-term outcome in TTS patients.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Psychiatric, neurological, and pulmonary pre-existing diseases are more common in TTS than in STEMI patients. Interestingly, PD and CVRF do not seem to have any impact on the short-term outcome of TTS patients.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s00508-024-02326-4","type":"journal-article","created":{"date-parts":[[2024,2,6]],"date-time":"2024-02-06T13:02:37Z","timestamp":1707224557000},"page":"691-699","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Effects of cardiovascular risk factors and pre-existing diseases on the short-term outcome of Takotsubo syndrome"],"prefix":"10.1007","volume":"136","author":[{"given":"Roya Anahita","family":"Mousavi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Schober","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Kronberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilie","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigitte","family":"Litschauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gernot","family":"Pichler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roza","family":"Badr Eslam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,2,6]]},"reference":[{"key":"2326_CR1","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.ijcard.2016.09.052","volume":"224","author":"S Wallstr\u00f6m","year":"2016","unstructured":"Wallstr\u00f6m\u00a0S, Ulin\u00a0K, Omerovic\u00a0E, Ekman\u00a0I. Self-reported symptoms 8\u00a0weeks after discharge: A\u00a0comparison of takotsubo syndrome and myocardial infarction. Int J Cardiol. 2016;224:348\u201352.","journal-title":"Int J Cardiol"},{"issue":"22","key":"2326_CR2","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1093\/eurheartj\/ehy076","volume":"39","author":"JR Ghadri","year":"2018","unstructured":"Ghadri\u00a0JR, Wittstein\u00a0IS, Prasad\u00a0A, Sharkey\u00a0S, Dote\u00a0K, Akashi\u00a0YJ, et\u00a0al. International Expert Consensus Document on Takotsubo Syndrome (Part I): Clinical Characteristics, Diagnostic Criteria, and Pathophysiology. Eur Heart\u00a0J. 2018;39(22):2032\u201346.","journal-title":"Eur Heart J"},{"key":"2326_CR3","doi-asserted-by":"crossref","unstructured":"Lyon AR, Citro R, Schneider B, Morel O, Ghadri JR, Templin C, et\u00a0al. Pathophysiology of Takotsubo Syndrome: JACC State-of-the-Art Review. Journal of the American College of Cardiology. 2021;77(7):902\u201321.","DOI":"10.1016\/j.jacc.2020.10.060"},{"issue":"6","key":"2326_CR4","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1002\/ejhf.494","volume":"18","author":"T Stiermaier","year":"2016","unstructured":"Stiermaier\u00a0T, Moeller\u00a0C, Oehler\u00a0K, Desch\u00a0S, Graf\u00a0T, Eitel\u00a0C, et\u00a0al. Long-term excess mortality in takotsubo cardiomyopathy: predictors, causes and clinical consequences. Eur J Heart Fail. 2016;18(6):650\u20136.","journal-title":"Eur J Heart Fail"},{"issue":"10","key":"2326_CR5","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1056\/NEJMoa1406761","volume":"373","author":"C Templin","year":"2015","unstructured":"Templin\u00a0C, Ghadri\u00a0JR, Diekmann\u00a0J, Napp\u00a0LC, Bataiosu\u00a0DR, Jaguszewski\u00a0M, et\u00a0al. Clinical Features and Outcomes of Takotsubo (Stress) Cardiomyopathy. N\u00a0Engl J Med. 2015;373(10):929\u201338.","journal-title":"N Engl J Med"},{"issue":"21","key":"2326_CR6","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1016\/j.jacc.2022.03.366","volume":"79","author":"L Arcari","year":"2022","unstructured":"Arcari\u00a0L, N\u00fa\u00f1ez\u00a0GIJ, Stiermaier\u00a0T, El-Battrawy\u00a0I, Guerra\u00a0F, Novo\u00a0G, et\u00a0al. Gender Differences in Takotsubo Syndrome. J\u00a0Am Coll Cardiol. 2022;79(21):2085\u201393.","journal-title":"J Am Coll Cardiol"},{"key":"2326_CR7","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.ijcard.2017.07.053","volume":"245","author":"T Stiermaier","year":"2017","unstructured":"Stiermaier\u00a0T, Santoro\u00a0F, Eitel\u00a0C, Graf\u00a0T, M\u00f6ller\u00a0C, Tarantino\u00a0N, et\u00a0al. Prevalence and prognostic relevance of atrial fibrillation in patients with Takotsubo syndrome. Int J Cardiol. 2017;245:156\u201361.","journal-title":"Int J Cardiol"},{"issue":"2","key":"2326_CR8","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1093\/eurheartj\/ehx393","volume":"39","author":"B Ibanez","year":"2018","unstructured":"Ibanez\u00a0B, James\u00a0S, Agewall\u00a0S, Antunes\u00a0MJ, Bucciarelli-Ducci\u00a0C, Bueno\u00a0H, et\u00a0al. 2017 ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the task force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European society of cardiology (ESC). Eur Heart\u00a0J. 2018;39(2):119\u201377.","journal-title":"Eur Heart J"},{"issue":"3","key":"2326_CR9","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/j.ahj.2007.11.008","volume":"155","author":"A Prasad","year":"2008","unstructured":"Prasad\u00a0A, Lerman\u00a0A, Rihal\u00a0CS. Apical ballooning syndrome (Tako-Tsubo or stress cardiomyopathy): a\u00a0mimic of acute myocardial infarction. Am Heart\u00a0J. 2008;155(3):408\u201317.","journal-title":"Am Heart J"},{"key":"2326_CR10","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1007\/s00508-021-01957-1","volume":"134(7-8","author":"V Weihs","year":"2022","unstructured":"Weihs\u00a0V, Pogran\u00a0E, Kunschitz\u00a0E, Weihs\u00a0W, Prinz\u00a0E, Eichenberg\u00a0C, et\u00a0al. Psychocardiological assessment in the acute phase of the takotsubo syndrome : Somatic and depressive disorders, resilience and illness perception. Wien Klin Wochenschr. 2022;134(7-8:269\u201375.","journal-title":"Wien Klin Wochenschr"},{"issue":"8","key":"2326_CR11","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1002\/clc.23661","volume":"44","author":"J Liang","year":"2021","unstructured":"Liang\u00a0J, Zhang\u00a0J, Xu\u00a0Y, Teng\u00a0C, Lu\u00a0X, Wang\u00a0Y, et\u00a0al. Conventional cardiovascular risk factors associated with Takotsubo cardiomyopathy: A\u00a0comprehensive review. Clin Cardiol. 2021;44(8):1033\u201340.","journal-title":"Clin Cardiol"},{"key":"2326_CR12","first-page":"e9","volume":"152(3):469","author":"A Elesber","year":"2006","unstructured":"Elesber\u00a0A, Lerman\u00a0A, Bybee\u00a0KA, Murphy\u00a0JG, Barsness\u00a0G, Singh\u00a0M, et\u00a0al. Myocardial perfusion in apical ballooning syndrome correlate of myocardial injury. Am Heart\u00a0J. 2006;152(3):469:e9\u201313.","journal-title":"Am Heart J"},{"issue":"11","key":"2326_CR13","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1016\/j.echo.2009.07.012","volume":"22","author":"SS Abdelmoneim","year":"2009","unstructured":"Abdelmoneim\u00a0SS, Mankad\u00a0SV, Bernier\u00a0M, Dhoble\u00a0A, Hagen\u00a0ME, Ness\u00a0SA, et\u00a0al. Microvascular function in Takotsubo cardiomyopathy with contrast echocardiography: prospective evaluation and review of literature. J\u00a0Am Soc Echocardiogr. 2009;22(11):1249\u201355.","journal-title":"J Am Soc Echocardiogr"},{"key":"2326_CR14","doi-asserted-by":"crossref","unstructured":"Sans-Rosell\u00f3 J, Fern\u00e1ndez-Peregrina E, Duran-Cambra A, Carreras-Mora J, Sionis A, \u00c1lvarez-Garc\u00eda J, et\u00a0al. Coronary Microvascular Dysfunction in Takotsubo Syndrome Assessed by Angiography-Derived Index of Microcirculatory Resistance: A\u00a0Pressure-Wire-Free Tool. J\u00a0Clin Med. 2021;10(19).","DOI":"10.3390\/jcm10194331"},{"key":"2326_CR15","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1161\/hc3101.091158","volume":"104(6","author":"BI Levy","year":"2001","unstructured":"Levy\u00a0BI, Ambrosio\u00a0G, Pries\u00a0AR, Struijker-Boudier\u00a0HA. Microcirculation in hypertension: a\u00a0new target for treatment? Circulation. 2001;104(6:735\u201340.","journal-title":"Circulation"},{"issue":"2","key":"2326_CR16","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1007\/s00125-015-3799-x","volume":"59","author":"BJ von Scholten","year":"2016","unstructured":"von Scholten\u00a0BJ, Hasbak\u00a0P, Christensen\u00a0TE, Ghotbi\u00a0AA, Kjaer\u00a0A, Rossing\u00a0P, et\u00a0al. Cardiac (82)Rb PET\/CT for fast and non-invasive assessment of microvascular function and structure in asymptomatic patients with type\u00a02 diabetes. Diabetologia. 2016;59(2):371\u20138.","journal-title":"Diabetologia"},{"issue":"6","key":"2326_CR17","doi-asserted-by":"publisher","first-page":"887","DOI":"10.2967\/jnumed.111.099325","volume":"53","author":"K Fukushima","year":"2012","unstructured":"Fukushima\u00a0K, Javadi\u00a0MS, Higuchi\u00a0T, Bravo\u00a0PE, Chien\u00a0D, Lautam\u00e4ki\u00a0R, et\u00a0al. Impaired global myocardial flow dynamics despite normal left ventricular function and regional perfusion in chronic kidney disease: a\u00a0quantitative analysis of clinical 82Rb PET\/CT studies. J\u00a0Nucl Med. 2012;53(6):887\u201393.","journal-title":"J Nucl Med"},{"issue":"10","key":"2326_CR18","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1136\/hrt.2006.100255","volume":"93","author":"H Gullu","year":"2007","unstructured":"Gullu\u00a0H, Caliskan\u00a0M, Ciftci\u00a0O, Erdogan\u00a0D, Topcu\u00a0S, Yildirim\u00a0E, et\u00a0al. Light cigarette smoking impairs coronary microvascular functions as severely as smoking regular cigarettes. Heart. 2007;93(10):1274\u20137.","journal-title":"Heart"},{"issue":"34","key":"2326_CR19","doi-asserted-by":"publisher","first-page":"3239","DOI":"10.1093\/eurheartj\/ehz915","volume":"41","author":"TJ Ford","year":"2020","unstructured":"Ford\u00a0TJ, Corcoran\u00a0D, Padmanabhan\u00a0S, Aman\u00a0A, Rocchiccioli\u00a0P, Good\u00a0R, et\u00a0al. Genetic dysregulation of endothelin\u20111 is implicated in coronary microvascular dysfunction. Eur Heart\u00a0J. 2020;41(34):3239\u201352.","journal-title":"Eur Heart J"},{"key":"2326_CR20","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1016\/j.jacc.2019.07.037","volume":"74(11","author":"F Emanuelsson","year":"2019","unstructured":"Emanuelsson\u00a0F, Nordestgaard\u00a0BG, Tybj\u00e6rg-Hansen\u00a0A, Benn\u00a0M. Impact of LDL Cholesterol on Microvascular Versus Macrovascular Disease: A\u00a0Mendelian Randomization Study. J\u00a0Am Coll Cardiol. 2019;74(11:1465\u201376.","journal-title":"J Am Coll Cardiol"},{"key":"2326_CR21","doi-asserted-by":"crossref","unstructured":"Zweiker D, Pogran E, Gargiulo L, El-Razek AA, Lechner I, Vosko I, et\u00a0al. Neutrophile-Lymphocyte Ratio and Outcome in Takotsubo Syndrome. Biol (basel). 2022;11(8).","DOI":"10.3390\/biology11081154"},{"issue":"1","key":"2326_CR22","doi-asserted-by":"publisher","first-page":"23555","DOI":"10.1038\/s41598-021-01496-9","volume":"11","author":"VL Cammann","year":"2021","unstructured":"Cammann\u00a0VL, Scheitz\u00a0JF, von Rennenberg\u00a0R, J\u00e4ncke\u00a0L, Nolte\u00a0CH, Szawan\u00a0KA, et\u00a0al. Clinical correlates and prognostic impact of neurologic disorders in Takotsubo syndrome. Sci Rep. 2021;11(1):23555.","journal-title":"Sci Rep"},{"key":"2326_CR23","doi-asserted-by":"publisher","first-page":"117","DOI":"10.2147\/DMSO.S282009","volume":"14","author":"P Li","year":"2021","unstructured":"Li\u00a0P, Lu\u00a0X, Teng\u00a0C, Hadley\u00a0M, Cai\u00a0P, Dai\u00a0Q, et\u00a0al. The Association Between Hyperlipidemia and In-Hospital Outcomes in Takotsubo Cardiomyopathy. Diabetes Metab Syndr Obes. 2021;14:117\u201326.","journal-title":"Diabetes Metab Syndr Obes"},{"issue":"8","key":"2326_CR24","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1007\/s00380-015-0729-2","volume":"31","author":"A Dias","year":"2016","unstructured":"Dias\u00a0A, Franco\u00a0E, Koshkelashvili\u00a0N, Bhalla\u00a0V, Pressman\u00a0GS, Hebert\u00a0K, et\u00a0al. Antiplatelet therapy in Takotsubo cardiomyopathy: does it improve cardiovascular outcomes during index event? Heart Vessels. 2016;31(8):1285\u201390.","journal-title":"Heart Vessels"},{"issue":"7","key":"2326_CR25","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1002\/clc.22280","volume":"37","author":"F Santoro","year":"2014","unstructured":"Santoro\u00a0F, Ieva\u00a0R, Musaico\u00a0F, Ferraretti\u00a0A, Triggiani\u00a0G, Tarantino\u00a0N, et\u00a0al. Lack of efficacy of drug therapy in preventing takotsubo cardiomyopathy recurrence: a\u00a0meta-analysis. Clin Cardiol. 2014;37(7):434\u20139.","journal-title":"Clin Cardiol"},{"issue":"5","key":"2326_CR26","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.2337\/dc17-2609","volume":"41","author":"T Stiermaier","year":"2018","unstructured":"Stiermaier\u00a0T, Santoro\u00a0F, El-Battrawy\u00a0I, M\u00f6ller\u00a0C, Graf\u00a0T, Novo\u00a0G, et\u00a0al. Prevalence and Prognostic Impact of Diabetes in Takotsubo Syndrome: Insights From the International, Multicenter GEIST Registry. Diabetes Care. 2018;41(5):1084\u20138.","journal-title":"Diabetes Care"},{"issue":"17","key":"2326_CR27","doi-asserted-by":"publisher","first-page":"e017290","DOI":"10.1161\/JAHA.119.017290","volume":"10","author":"B Redfors","year":"2021","unstructured":"Redfors\u00a0B, Jha\u00a0S, Thorleifsson\u00a0S, Jernberg\u00a0T, Anger\u00e5s\u00a0O, Frobert\u00a0O, et\u00a0al. Short- and Long-Term Clinical Outcomes for Patients With Takotsubo Syndrome and Patients With Myocardial Infarction: A\u00a0Report From the Swedish Coronary Angiography and Angioplasty Registry. J\u00a0Am Heart Assoc. 2021;10(17):e17290.","journal-title":"J Am Heart Assoc"},{"key":"2326_CR28","doi-asserted-by":"crossref","unstructured":"Li P, Jin C, Cui C, Cai P, Manohar SA, Jin L, et\u00a0al. Impact of family history of coronary artery disease on clinical outcomes in Takotsubo cardiomyopathy. J\u00a0Investig Med. 2022;.","DOI":"10.1136\/jim-2021-002186"},{"key":"2326_CR29","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s00508-021-01925-9","volume":"134(7-8","author":"E Pogran","year":"2022","unstructured":"Pogran\u00a0E, El-Razek\u00a0AA, Gargiulo\u00a0L, Weihs\u00a0V, Kaufmann\u00a0C, Horv\u00e1th\u00a0S, et\u00a0al. Long-term outcome in patients with takotsubo syndrome : A\u00a0single center study from Vienna. Wien Klin Wochenschr. 2022;134(7-8:261\u20138.","journal-title":"Wien Klin Wochenschr"},{"issue":"2","key":"2326_CR30","doi-asserted-by":"publisher","first-page":"188","DOI":"10.2174\/1573403X16666200129114330","volume":"17","author":"ES Prokudina","year":"2021","unstructured":"Prokudina\u00a0ES, Kurbatov\u00a0BK, Zavadovsky\u00a0KV, Vrublevsky\u00a0AV, Naryzhnaya\u00a0NV, Lishmanov\u00a0YB, et\u00a0al. Takotsubo Syndrome: Clinical Manifestations, Etiology and Pathogenesis. Curr Cardiol Rev. 2021;17(2):188\u2013203.","journal-title":"Curr Cardiol Rev"}],"container-title":["Wiener klinische Wochenschrift"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00508-024-02326-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00508-024-02326-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00508-024-02326-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T00:07:38Z","timestamp":1733875658000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00508-024-02326-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,6]]},"references-count":30,"journal-issue":{"issue":"23-24","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["2326"],"URL":"https:\/\/doi.org\/10.1007\/s00508-024-02326-4","relation":{},"ISSN":["0043-5325","1613-7671"],"issn-type":[{"value":"0043-5325","type":"print"},{"value":"1613-7671","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,6]]},"assertion":[{"value":"5 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"R.\u00a0A.\u00a0Mousavi, A.\u00a0Schober, C.\u00a0Kronberger, E.\u00a0Han, B.\u00a0Litschauer, G.\u00a0Pichler and R.\u00a0Badr Eslam declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants or on human tissue were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1975 Helsinki declaration and its later amendments or comparable ethical standards. This study was approved by the Ethics Committee of the Medical University of Vienna and the Ethics Committee of the City of Vienna.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical standards"}}]}}